April 2023 - Volume 30 - Issue 4 : Menopause

Previous Issue | Next Issue

April 2023 - Volume 30 - Issue 4

pp: 355-461

Table of Contents Outline

Contributor Index

Editorials

Is the vaginal microbiome a marker or an effector of vaginal health?

Mitchell, Caroline M.

Menopause. 30(4):355-356, April 2023.

PDF
Permissions

Complexities of intimate partner violence and insomnia: why some midlife women cannot sleep

Shaver, Joan Fowler; Woods, Nancy Fugate

Menopause. 30(4):357-360, April 2023.

PDF
Permissions

Original Studies

Effect of ospemifene on vaginal microbiome in postmenopausal women with vulvovaginal atrophy

Alvisi, Stefania; Ceccarani, Camilla; Foschi, Claudio; More

Menopause. 30(4):361-369, April 2023.

Lifetime history of interpersonal partner violence is associated with insomnia among midlife women veterans

Goldstein, Lizabeth A.; Jakubowski, Karen P.; Huang, Alison J.; More

Menopause. 30(4):370-375, April 2023.

Migraine and sleep quality: does the association change in midlife women?

Faubion, Stephanie S.; Ghaith, Summer; Kling, Juliana M.; More

Menopause. 30(4):376-382, April 2023.

Safety and effectiveness of a novel home-use therapeutic ultrasound device for the treatment of vaginal dryness in postmenopausal women: a pilot study

Hickey, Martha; Baber, Rodney; Eden, John; More

Menopause. 30(4):383-392, April 2023.

Maternal age at birth of last child and cardiovascular disease mortality later in life among a national cohort of postmenopausal women from the United States

Appiah, Duke; Kim, Catherine; Fuquay, Taylor; More

Menopause. 30(4):393-400, April 2023.

Menopause in people with cystic fibrosis

Prochownik, Katherine; Jain, Raksha; Taylor-Cousar, Jennifer L.; More

Menopause. 30(4):401-405, April 2023.

Does the addition of serum antimüllerian hormone concentrations to the Framingham Risk Score and Pooled Cohort Equations improve the prediction of cardiovascular disease?

Amiri, Mina; Ahmadi, Narjes; Hadaegh, Farzad; More

Menopause. 30(4):406-413, April 2023.

Efficacy of Erbium YAG laser treatment in overactive bladder syndrome: a randomized controlled trial

Chiengthong, Keerati; Bunyavejchevin, Suvit

Menopause. 30(4):414-420, April 2023.

Associations between the impact of menopausal symptoms and fall-related self-efficacy

Espírito Santo, João; Hita-Contreras, Fidel; Marques de Loureiro, Nuno Eduardo; More

Menopause. 30(4):421-426, April 2023.

Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study

Hull, Louise; Stuckey, Bronwyn G. A.; Hartman, Kimberly; More

Menopause. 30(4):427-436, April 2023.

Sleep duration and the onset of menopause in Japanese women

Nagata, Chisato; Wada, Keiko; Yamakawa, Michiyo; More

Menopause. 30(4):437-440, April 2023.

Effectiveness of vaginal estriol with lactobacilli on urinary symptoms in postmenopausal women: a randomized-controlled trial

Jongjakapun, Apiwat; Somboonporn, Woraluk; Temtanakitpaisan, Teerayut

Menopause. 30(4):441-446, April 2023.

Epidemiological study of genitourinary syndrome of menopause in Japan (GENJA study)

Tomoe, Hikaru; Ozaki, Yumi; Yamamoto, Mayuko; More

Menopause. 30(4):447-453, April 2023.

Review Article

The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context

Chlebowski, Rowan T.; Aragaki, Aaron K.

Menopause. 30(4):454-461, April 2023.

Secondary Logo

Journal Logo

Editorials

Is the vaginal microbiome a marker or an effector of vaginal health?

Complexities of intimate partner violence and insomnia: why some midlife women cannot sleep

Original Studies

Effect of ospemifene on vaginal microbiome in postmenopausal women with vulvovaginal atrophy

In Brief:

Lifetime history of interpersonal partner violence is associated with insomnia among midlife women veterans

In Brief:

Migraine and sleep quality: does the association change in midlife women?

In Brief:

Safety and effectiveness of a novel home-use therapeutic ultrasound device for the treatment of vaginal dryness in postmenopausal women: a pilot study

Maternal age at birth of last child and cardiovascular disease mortality later in life among a national cohort of postmenopausal women from the United States

Menopause in people with cystic fibrosis

Does the addition of serum antimüllerian hormone concentrations to the Framingham Risk Score and Pooled Cohort Equations improve the prediction of cardiovascular disease?

Efficacy of Erbium YAG laser treatment in overactive bladder syndrome: a randomized controlled trial

Associations between the impact of menopausal symptoms and fall-related self-efficacy

In Brief:

Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic study

In Brief:

Sleep duration and the onset of menopause in Japanese women

In Brief:

Effectiveness of vaginal estriol with lactobacilli on urinary symptoms in postmenopausal women: a randomized-controlled trial

In Brief:

Epidemiological study of genitourinary syndrome of menopause in Japan (GENJA study)

In Brief:

Review Article

The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context

In Brief:

Future Table of Contents